Literature DB >> 10348787

In vitro antifungal susceptibilities of Scopulariopsis isolates.

C Aguilar1, I Pujol, J Guarro.   

Abstract

MICs and minimum fungicidal concentrations of amphotericin B, miconazole, itraconazole, ketoconazole, fluconazole, and flucytosine against 17 isolates of Scopulariopsis spp. were determined by a broth microdilution method. All the isolates were resistant to itraconazole, fluconazole, and flucytosine, and amphotericin B, miconazole, and ketoconazole MICs were low for only a few.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10348787      PMCID: PMC89313          DOI: 10.1128/AAC.43.6.1520

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  21 in total

1.  Scopulariopsis peritonitis in a patient undergoing continuous ambulatory peritoneal dialysis.

Authors:  P S Vaidya; J F Levine
Journal:  Perit Dial Int       Date:  1992       Impact factor: 1.756

2.  A case of fungal keratitis caused by Scopulariopsis brevicaulis: treatment with antifungal agents and penetrating keratoplasty.

Authors:  N K Ragge; J C Hart; D L Easty; A G Tyers
Journal:  Br J Ophthalmol       Date:  1990-09       Impact factor: 4.638

3.  Comparison of in vitro antifungal susceptibilities of conidia and hyphae of filamentous fungi.

Authors:  J Guarro; C Llop; C Aguilar; I Pujol
Journal:  Antimicrob Agents Chemother       Date:  1997-12       Impact factor: 5.191

4.  A case of mycetoma caused by Scopulariopsis maduromycosis.

Authors:  D L Wang; C Xu; G C Wang
Journal:  Chin Med J (Engl)       Date:  1986-05       Impact factor: 2.628

5.  Invasive Scopulariopsis in the immunocompromised host.

Authors:  J P Neglia; D D Hurd; P Ferrieri; D C Snover
Journal:  Am J Med       Date:  1987-12       Impact factor: 4.965

6.  Fungal keratitis caused by Scopulariopsis brevicaulis: successful treatment with topical amphotericin B and chloramphenicol without the need for surgical debridement.

Authors:  A J Lotery; J R Kerr; B A Page
Journal:  Br J Ophthalmol       Date:  1994-09       Impact factor: 4.638

7.  Invasive hyalohyphomycosis caused by Scopulariopsis brevicaulis in a patient undergoing allogeneic bone marrow transplant.

Authors:  P Phillips; W S Wood; G Phillips; M G Rinaldi
Journal:  Diagn Microbiol Infect Dis       Date:  1989 Sep-Oct       Impact factor: 2.803

8.  Deep scopulariopsosis: a case report and sensitivity studies.

Authors:  A S Sekhon; D J Willans; J H Harvey
Journal:  J Clin Pathol       Date:  1974-10       Impact factor: 3.411

9.  Opportunistic Scopulariopsis pneumonia in an immunocompromised host.

Authors:  L J Wheat; M Bartlett; M Ciccarelli; J W Smith
Journal:  South Med J       Date:  1984-12       Impact factor: 0.954

10.  Onychomycosis caused by Scopulariopsis brumptii. A case report and sensitivity studies.

Authors:  J Naidu; S M Singh; M Pouranik
Journal:  Mycopathologia       Date:  1991-03       Impact factor: 2.574

View more
  10 in total

1.  Scopulariopsis brevicaulis, a fungal pathogen resistant to broad-spectrum antifungal agents.

Authors:  Manuel Cuenca-Estrella; Alicia Gomez-Lopez; Emilia Mellado; Maria J Buitrago; Araceli Monzón; Juan L Rodriguez-Tudela
Journal:  Antimicrob Agents Chemother       Date:  2003-07       Impact factor: 5.191

2.  Scopulariopsis, a poorly known opportunistic fungus: spectrum of species in clinical samples and in vitro responses to antifungal drugs.

Authors:  Marcelo Sandoval-Denis; Deanna A Sutton; Annette W Fothergill; Josep Cano-Lira; Josepa Gené; C A Decock; G S de Hoog; Josep Guarro
Journal:  J Clin Microbiol       Date:  2013-09-11       Impact factor: 5.948

3.  In vitro activities of 10 combinations of antifungal agents against the multiresistant pathogen Scopulariopsis brevicaulis.

Authors:  Manuel Cuenca-Estrella; Alicia Gomez-Lopez; Maria J Buitrago; Emilia Mellado; Guillermo Garcia-Effron; Juan L Rodriguez-Tudela
Journal:  Antimicrob Agents Chemother       Date:  2006-06       Impact factor: 5.191

4.  In vitro activities of a wide panel of antifungal drugs against various Scopulariopsis and Microascus species.

Authors:  Magdalena Skóra; Małgorzata Bulanda; Tomasz Jagielski
Journal:  Antimicrob Agents Chemother       Date:  2015-06-22       Impact factor: 5.191

5.  Utility of inoculum counting (Walshe and English criteria) in clinical diagnosis of onychomycosis caused by nondermatophytic filamentous fungi.

Authors:  A K Gupta; E A Cooper; P MacDonald; R C Summerbell
Journal:  J Clin Microbiol       Date:  2001-06       Impact factor: 5.948

6.  Virulence and Resistance to Antifungal Therapies of Scopulariopsis Species.

Authors:  Katihuska Paredes; Javier Capilla; Emilio Mayayo; Josep Guarro
Journal:  Antimicrob Agents Chemother       Date:  2016-03-25       Impact factor: 5.191

7.  Fatal Scopulariopsis infection in a lung transplant recipient: lessons of organ procurement.

Authors:  C M Shaver; J L Castilho; D N Cohen; E L Grogan; G G Miller; J S Dummer; J N Gray; E S Lambright; J E Loyd; I M Robbins
Journal:  Am J Transplant       Date:  2014-11-06       Impact factor: 8.086

8.  Fatal invasive infection with fungemia due to Microascus cirrosus after heart and lung transplantation in a patient with cystic fibrosis.

Authors:  Charline Miossec; Florent Morio; Thierry Lepoivre; Patrice Le Pape; Dea Garcia-Hermoso; Françoise Gay-Andrieu; Alain Haloun; Michele Treilhaud; François Leclair; Michel Miegeville
Journal:  J Clin Microbiol       Date:  2011-05-04       Impact factor: 5.948

9.  In Vitro Triple Combination of Antifungal Drugs against Clinical Scopulariopsis and Microascus Species.

Authors:  Limin Yao; Zhe Wan; Ruoyu Li; Jin Yu
Journal:  Antimicrob Agents Chemother       Date:  2015-05-26       Impact factor: 5.191

10.  Invasive Microascus trigonosporus Species Complex Pulmonary Infection in a Lung Transplant Recipient.

Authors:  Kelly E Schoeppler; Martin R Zamora; Noelle M Northcutt; Gerard R Barber; Gayle O'Malley-Schroeder; Dennis M Lyu
Journal:  Case Rep Transplant       Date:  2015-05-14
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.